Verastem (VSTM) Net Income Growth (3y) (2014 - 2026)
Verastem (VSTM) Net Income Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | 9.16% |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - | - |
| 4 | BeOne Medicines | 472.11 Bn | 467.32 Bn | 1.35 Bn | 38.43% |
| 5 | Vertex Pharmaceuticals | 121.89 Bn | 114.65 Bn | 2.59 Bn | 13.80% |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn | -3.84% |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - | - |
| 8 | Argenx Se | 55.82 Bn | 50.63 Bn | 1.41 Bn | 79.26% |
| 9 | Revolution Medicines | 37.49 Bn | 37.49 Bn | - | - |
| 10 | Verastem | 616.78 Mn | 418.96 Mn | 15.90 Mn | -32.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.44% |
| Dec 31, 2025 | 29.87% |
| Sep 30, 2025 | -34.57% |
| Jun 30, 2025 | -34.94% |
| Mar 31, 2025 | -37.21% |
| Dec 31, 2024 | -24.71% |
| Sep 30, 2024 | -14.40% |
| Jun 30, 2024 | 19.08% |
| Mar 31, 2024 | -16.49% |
| Dec 31, 2023 | -14.61% |
| Sep 30, 2023 | -52.36% |
| Jun 30, 2023 | 4.11% |
| Mar 31, 2023 | 20.43% |
| Dec 31, 2022 | 23.91% |
| Sep 30, 2022 | 15.52% |
| Jun 30, 2022 | 19.56% |
| Mar 31, 2022 | 23.30% |
| Dec 31, 2021 | 23.56% |
| Sep 30, 2021 | 24.47% |
| Jun 30, 2021 | 12.91% |